ArticlePolymers2025
Enhanced Adsorption of Metformin Using Cu and ZnO Nanoparticles Anchored on Carboxylated Graphene Oxide.
Article in Polymers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Pharmaceutical residues are increasingly emerging in global drinking water sources, posing serious ecological and public health challenges by altering the physicochemical balance of aquatic systems. Among available purification approaches, adsorption remains one of the most promising techniques due to its simplicity, cost-effectiveness, and efficiency. In this work, a ternary nanocomposite of Cu- and ZnO-decorated carboxylated graphene oxide (Cu/ZnO@CGO) was synthesized and utilized for highly efficient and ultrafast removal of the antidiabetic drug metformin from aqueous environments. The adsorption mechanism arises from a synergistic combination of surface complexation on Cu nanoparticles, cation-π and π-π electron donor-acceptor interactions with the CGO aromatic structure, and hydrogen bonding through the amino groups of metformin and the oxygen-rich functional moieties of ZnO and CGO. The nanocomposite was thoroughly characterized using FTIR, XPS, XRD, SEM, HRTEM, and TGA analyses, confirming its well-defined hybrid structure. Unlike conventional single-phase or binary systems, the Cu/ZnO@CGO nanocomposite demonstrated remarkable cooperative effects that enhanced its performance through the integration of metal-ligand coordination, π-π stacking, cation-π forces, and hydrogen bonding. These interactions contributed to an outstanding adsorption capacity of 232.56 mg·g
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.